CMR316
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CMR316, covering 2025-04-23 to 2025-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis [Phase 1]